卖什么
Enabling T cell immunotherapy discovery, development and manufacturing
商业模式拆解
买家：谁掌握预算？
Cell therapy R&D and process development groups at pharma/biotech (site cites 3 top pharmaceutical companies using Hydropore).
触发点：什么让他们现在购买？
Gene transfer step is the bottleneck in cell therapy manufacturing; viral transduction and electroporation add cost, lead time and regulatory risk.
工作流：什么输入变成什么输出？
Hydropore uses microfluidic vortex shedding on a 5x10mm chip (>50M cells, 2-4M cells/sec) to deliver small molecules, mRNA, CRISPR RNPs into immune cells for discovery, development and manufacturing.
经济账：省了什么，怎么收费？
未核实Sale of Hydropore devices/chips (site: "Order Hydropore") and licensing/partnership for manufacturing.
渠道：怎么接触到客户？
Direct orders and "Partner with Us"; no self-serve pricing.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| — | YC 2017 冬季 | — | Y Combinator | ycombinator.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.